{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:03:34Z","timestamp":1789898614841,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammatory bowel disease (IBD) may develop due to an inflammatory response to commensal gut microbiota triggered by environmental factors in a genetically susceptible host. Isotretinoin (acne therapy) has been inconsistently associated with IBD onset and flares but prior treatment with antibiotics, also associated with IBD development, complicates the confirmation of this association. Here we studied in mice whether doxycycline, metronidazole or isotretinoin induce epigenetic modifications, and consequently change T-cell mRNA expression and\/or function directly after treatment and after a 4 week recovery period. Isotretinoin induced IL-10 signaling in Tregs and naive T-cells directly after treatment and reduced effector T-cell proliferation alone and in co-culture with Tregs. Metronidazole activated processes associated with anti-inflammatory pathways in both T-cell subsets directly after the treatment period whereas doxycycline induced an immediate pro-inflammatory expression profile that resolved after the recovery period. Long-term changes indicated an inhibition of proliferation by doxycycline and induction of beneficial immune and metabolic pathways by metronidazole. Persistent alterations in microRNA and mRNA expression profiles after the recovery period indicate that all three medications may induce long-term epigenetic modifications in both T-cell subsets. Yet, our data do not support the induction of a long-term pro-inflammatory phenotype in murine Tregs and naive T-cells.<\/jats:p>","DOI":"10.1038\/srep37082","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T12:58:56Z","timestamp":1479387536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Doxycycline, metronidazole and isotretinoin: Do they modify microRNA\/mRNA expression profiles and function in murine T-cells?"],"prefix":"10.1038","volume":"6","author":[{"given":"Eugenia","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bengs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirisha","family":"Aluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstin","family":"Atrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Stanzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A. Ruiz","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Rogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Frey-Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"key":"BFsrep37082_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46\u201354 e42; quiz e30, doi: 10.1053\/j.gastro.2011.10.001 (2012).","journal-title":"Gastroenterology"},{"key":"BFsrep37082_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307\u2013317, doi: 10.1038\/nature10209 (2011).","journal-title":"Nature"},{"key":"BFsrep37082_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119\u2013124, doi: 10.1038\/nature11582 (2012).","journal-title":"Nature"},{"key":"BFsrep37082_CR4","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1053\/j.gastro.2015.07.065","volume":"149","author":"C Huang","year":"2015","unstructured":"Huang, C. et al. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. Gastroenterology 149, 1575\u20131586, doi: 10.1053\/j.gastro.2015.07.065 (2015).","journal-title":"Gastroenterology"},{"key":"BFsrep37082_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47, 979\u2013986, doi: 10.1038\/ng.3359 (2015).","journal-title":"Nat Genet"},{"key":"BFsrep37082_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.07.002","volume":"11","author":"M Iborra","year":"2012","unstructured":"Iborra, M., Bernuzzi, F., Invernizzi, P. & Danese, S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev 11, 305\u2013314, doi: 10.1016\/j.autrev.2010.07.002 (2012).","journal-title":"Autoimmun Rev"},{"key":"BFsrep37082_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/gutjnl-2014-307891","volume":"64","author":"R Kalla","year":"2015","unstructured":"Kalla, R. et al. MicroRNAs: new players in IBD. Gut 64, 504\u2013517, doi: 10.1136\/gutjnl-2014-307891 (2015).","journal-title":"Gut"},{"key":"BFsrep37082_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ibd.21691","volume":"18","author":"JR Pekow","year":"2012","unstructured":"Pekow, J. R. & Kwon, J. H. MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis 18, 187\u2013193, doi: 10.1002\/ibd.21691 (2012).","journal-title":"Inflamm Bowel Dis"},{"key":"BFsrep37082_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7150\/ijms.8647","volume":"11","author":"X Ma","year":"2014","unstructured":"Ma, X. et al. Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci 11, 810\u2013818, doi: 10.7150\/ijms.8647 (2014).","journal-title":"Int J Med Sci"},{"key":"BFsrep37082_CR10","doi-asserted-by":"publisher","first-page":"e2030","DOI":"10.1097\/MD.0000000000002030","volume":"94","author":"RY Huang","year":"2015","unstructured":"Huang, R. Y. et al. An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature. Medicine (Baltimore) 94, e2030, doi: 10.1097\/MD.0000000000002030 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"BFsrep37082_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clim.2012.04.005","volume":"144","author":"G Amarilyo","year":"2012","unstructured":"Amarilyo, G. & La Cava, A. miRNA in systemic lupus erythematosus. Clin Immunol 144, 26\u201331, doi: 10.1016\/j.clim.2012.04.005 (2012).","journal-title":"Clin Immunol"},{"key":"BFsrep37082_CR12","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.yexcr.2008.02.023","volume":"314","author":"JM Sedivy","year":"2008","unstructured":"Sedivy, J. M., Banumathy, G. & Adams, P. D. Aging by epigenetics\u2013a consequence of chromatin damage? Exp Cell Res 314, 1909\u20131917, doi: 10.1016\/j.yexcr.2008.02.023 (2008).","journal-title":"Exp Cell Res"},{"key":"BFsrep37082_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrd4359","volume":"13","author":"Z Li","year":"2014","unstructured":"Li, Z. & Rana, T. M. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 13, 622\u2013638, doi: 10.1038\/nrd4359 (2014).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep37082_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/gut.2010.219683","volume":"60","author":"A Hviid","year":"2011","unstructured":"Hviid, A., Svanstrom, H. & Frisch, M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 60, 49\u201354, doi: 10.1136\/gut.2010.219683 (2011).","journal-title":"Gut"},{"key":"BFsrep37082_CR15","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/ajg.2010.303","volume":"105","author":"DJ Margolis","year":"2010","unstructured":"Margolis, D. J., Fanelli, M., Hoffstad, O. & Lewis, J. D. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. The American journal of gastroenterology 105, 2610\u20132616, doi: 10.1038\/ajg.2010.303 (2010).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR16","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/ajg.2010.398","volume":"105","author":"SY Shaw","year":"2010","unstructured":"Shaw, S. Y., Blanchard, J. F. & Bernstein, C. N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. The American journal of gastroenterology 105, 2687\u20132692, doi: 10.1038\/ajg.2010.398 (2010).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/ajg.2011.304","volume":"106","author":"SY Shaw","year":"2011","unstructured":"Shaw, S. Y., Blanchard, J. F. & Bernstein, C. N. Association between the use of antibiotics and new diagnoses of Crohn\u2019s disease and ulcerative colitis. The American journal of gastroenterology 106, 2133\u20132142, doi: 10.1038\/ajg.2011.304 (2011).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR18","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/ajg.2014.246","volume":"109","author":"R Ungaro","year":"2014","unstructured":"Ungaro, R. et al. Antibiotics associated with increased risk of new-onset Crohn\u2019s disease but not ulcerative colitis: a meta-analysis. The American journal of gastroenterology 109, 1728\u20131738, doi: 10.1038\/ajg.2014.246 (2014).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR19","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/ajg.2010.124","volume":"105","author":"SD Crockett","year":"2010","unstructured":"Crockett, S. D., Porter, C. Q., Martin, C. F., Sandler, R. S. & Kappelman, M. D. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. The American journal of gastroenterology 105, 1986\u20131993, doi: 10.1038\/ajg.2010.124 (2010).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR20","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1572-0241.2006.00632.x","volume":"101","author":"D Reddy","year":"2006","unstructured":"Reddy, D., Siegel, C. A., Sands, B. E. & Kane, S. Possible association between isotretinoin and inflammatory bowel disease. The American journal of gastroenterology 101, 1569\u20131573, doi: 10.1111\/j.1572-0241.2006.00632.x (2006).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/gut.2008.170530","volume":"58","author":"M Shale","year":"2009","unstructured":"Shale, M., Kaplan, G. G., Panaccione, R. & Ghosh, S. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut 58, 737\u2013741, doi: 10.1136\/gut.2008.170530 (2009).","journal-title":"Gut"},{"key":"BFsrep37082_CR22","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1038\/ajg.2009.417","volume":"104","author":"CN Bernstein","year":"2009","unstructured":"Bernstein, C. N., Nugent, Z., Longobardi, T. & Blanchard, J. F. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. The American journal of gastroenterology 104, 2774\u20132778, doi: 10.1038\/ajg.2009.417 (2009).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/archdermatol.2011.116","volume":"147","author":"CM Popescu","year":"2011","unstructured":"Popescu, C. M. & Popescu, R. Isotretinoin therapy and inflammatory bowel disease. Arch Dermatol 147, 724\u2013729, doi: 10.1001\/archdermatol.2011.116 (2011).","journal-title":"Arch Dermatol"},{"key":"BFsrep37082_CR24","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ajg.2011.28","volume":"106","author":"BT Thakrar","year":"2011","unstructured":"Thakrar, B. T. & Robinson, N. J. Isotretinoin use and the risk of inflammatory bowel disease. The American journal of gastroenterology 106, 1000\u20131002; author reply 1002-1003, doi: 10.1038\/ajg.2011.28 (2011).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"HC Williams","year":"2012","unstructured":"Williams, H. C., Dellavalle, R. P. & Garner, S. Acne vulgaris. Lancet 379, 361\u2013372, doi: 10.1016\/S0140-6736(11)60321-8 (2012).","journal-title":"Lancet"},{"key":"BFsrep37082_CR26","first-page":"199","volume":"1","author":"AD Bachstetter","year":"2010","unstructured":"Bachstetter, A. D. & Van Eldik, L. J. The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS. Aging Dis 1, 199\u2013211 (2010).","journal-title":"Aging Dis"},{"key":"BFsrep37082_CR27","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1038\/onc.2011.499","volume":"31","author":"A Piskunov","year":"2012","unstructured":"Piskunov, A. & Rochette-Egly, C. A retinoic acid receptor RARalpha pool present in membrane lipid rafts forms complexes with G protein alphaQ to activate p38MAPK. Oncogene 31, 3333\u20133345, doi: 10.1038\/onc.2011.499 (2012).","journal-title":"Oncogene"},{"key":"BFsrep37082_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli, A. E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13, 271\u2013282, doi: 10.1038\/nrg3162 (2012).","journal-title":"Nat Rev Genet"},{"key":"BFsrep37082_CR29","first-page":"199","volume":"1","author":"T Philllips","year":"2008","unstructured":"Philllips, T. Regulation of Transcription and Gene Expression in Eukaryotes. Nature Education 1, 199 (2008).","journal-title":"Nature Education"},{"key":"BFsrep37082_CR30","first-page":"115","volume":"1","author":"T Phillips","year":"2008","unstructured":"Phillips, T. Small non-coding RNA and gene expression. Nature Education 1, 115 (2008).","journal-title":"Nature Education"},{"key":"BFsrep37082_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64\u201371, doi: 10.1038\/nature07242 (2008).","journal-title":"Nature"},{"key":"BFsrep37082_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri.2016.40","volume":"16","author":"A Mehta","year":"2016","unstructured":"Mehta, A. & Baltimore, D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol 16, 279\u2013294, doi: 10.1038\/nri.2016.40 (2016).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep37082_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.12.006","volume":"331","author":"Z Wang","year":"2013","unstructured":"Wang, Z. et al. Transcriptional and epigenetic regulation of human microRNAs. Cancer Lett 331, 1\u201310, doi: 10.1016\/j.canlet.2012.12.006 (2013).","journal-title":"Cancer Lett"},{"key":"BFsrep37082_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4291\/wjgp.v5.i2.63","volume":"5","author":"WX Chen","year":"2014","unstructured":"Chen, W. X., Ren, L. H. & Shi, R. H. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol 5, 63\u201370, doi: 10.4291\/wjgp.v5.i2.63 (2014).","journal-title":"World J Gastrointest Pathophysiol"},{"key":"BFsrep37082_CR35","doi-asserted-by":"publisher","first-page":"12274","DOI":"10.3748\/wjg.v21.i43.12274","volume":"21","author":"K Fisher","year":"2015","unstructured":"Fisher, K. & Lin, J. MicroRNA in inflammatory bowel disease: Translational research and clinical implication. World J Gastroenterol 21, 12274\u201312282, doi: 10.3748\/wjg.v21.i43.12274 (2015).","journal-title":"World J Gastroenterol"},{"key":"BFsrep37082_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fgene.2014.00347","volume":"5","author":"MC Runtsch","year":"2014","unstructured":"Runtsch, M. C., Round, J. L. & O\u2019Connell, R. M. MicroRNAs and the regulation of intestinal homeostasis. Front Genet 5, 347, doi: 10.3389\/fgene.2014.00347 (2014).","journal-title":"Front Genet"},{"key":"BFsrep37082_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12865-015-0069-0","volume":"16","author":"JS Schaefer","year":"2015","unstructured":"Schaefer, J. S. et al. MicroRNA signatures differentiate Crohn\u2019s disease from ulcerative colitis. BMC Immunol 16, 5, doi: 10.1186\/s12865-015-0069-0 (2015).","journal-title":"BMC Immunol"},{"key":"BFsrep37082_CR38","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1053\/j.gastro.2008.07.068","volume":"135","author":"F Wu","year":"2008","unstructured":"Wu, F. et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135, 1624\u20131635 e1624, doi: 10.1053\/j.gastro.2008.07.068 (2008).","journal-title":"Gastroenterology"},{"key":"BFsrep37082_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2011.07.002","volume":"35","author":"JA Hall","year":"2011","unstructured":"Hall, J. A., Grainger, J. R., Spencer, S. P. & Belkaid, Y. The role of retinoic acid in tolerance and immunity. Immunity 35, 13\u201322, doi: 10.1016\/j.immuni.2011.07.002 (2011).","journal-title":"Immunity"},{"key":"BFsrep37082_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/cmi.2014.133","volume":"12","author":"ZM Liu","year":"2015","unstructured":"Liu, Z. M., Wang, K. P., Ma, J. & Guo Zheng, S. The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells. Cell Mol Immunol 12, 553\u2013557, doi: 10.1038\/cmi.2014.133 (2015).","journal-title":"Cell Mol Immunol"},{"key":"BFsrep37082_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2009.03.008","volume":"30","author":"D Mucida","year":"2009","unstructured":"Mucida, D. et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 30, 471\u2013472; author reply 472-473, doi: 10.1016\/j.immuni.2009.03.008 (2009).","journal-title":"Immunity"},{"key":"BFsrep37082_CR42","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.4049\/jimmunol.1000598","volume":"185","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 185, 2675\u20132679, doi: 10.4049\/jimmunol.1000598 (2010).","journal-title":"J Immunol"},{"key":"BFsrep37082_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/imr.12049","volume":"253","author":"J Dooley","year":"2013","unstructured":"Dooley, J., Linterman, M. A. & Liston, A. MicroRNA regulation of T-cell development. Immunol Rev 253, 53\u201364, doi: 10.1111\/imr.12049 (2013).","journal-title":"Immunol Rev"},{"key":"BFsrep37082_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-94-017-9050-5_6","volume":"70","author":"A Piskunov","year":"2014","unstructured":"Piskunov, A., Al Tanoury, Z. & Rochette-Egly, C. Nuclear and extra-nuclear effects of retinoid acid receptors: how they are interconnected. Subcell Biochem 70, 103\u2013127, doi: 10.1007\/978-94-017-9050-5_6 (2014).","journal-title":"Subcell Biochem"},{"key":"BFsrep37082_CR45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2009.09.009","volume":"30","author":"DC Palmer","year":"2009","unstructured":"Palmer, D. C. & Restifo, N. P. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol 30, 592\u2013602, doi: 10.1016\/j.it.2009.09.009 (2009).","journal-title":"Trends Immunol"},{"key":"BFsrep37082_CR46","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/eji.200737193","volume":"37","author":"BB Pillemer","year":"2007","unstructured":"Pillemer, B. B., Xu, H., Oriss, T. B., Qi, Z. & Ray, A. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function. Eur J Immunol 37, 2082\u20132089, doi: 10.1002\/eji.200737193 (2007).","journal-title":"Eur J Immunol"},{"key":"BFsrep37082_CR47","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1084\/jem.20052333","volume":"203","author":"I Kinjyo","year":"2006","unstructured":"Kinjyo, I. et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J Exp Med 203, 1021\u20131031, doi: 10.1084\/jem.20052333 (2006).","journal-title":"J Exp Med"},{"key":"BFsrep37082_CR48","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/ni.2113","volume":"12","author":"Z Liu","year":"2011","unstructured":"Liu, Z. et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol 12, 1063\u20131070, doi: 10.1038\/ni.2113 (2011).","journal-title":"Nat Immunol"},{"key":"BFsrep37082_CR49","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1084\/jem.20072484","volume":"205","author":"B Weigmann","year":"2008","unstructured":"Weigmann, B. et al. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. The Journal of experimental medicine 205, 2099\u20132110, doi: 10.1084\/jem.20072484 (2008).","journal-title":"The Journal of experimental medicine"},{"key":"BFsrep37082_CR50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1574-6941.2010.00916.x","volume":"73","author":"MA Pelissier","year":"2010","unstructured":"Pelissier, M. A. et al. Metronidazole effects on microbiota and mucus layer thickness in the rat gut. FEMS Microbiol Ecol 73, 601\u2013610, doi: 10.1111\/j.1574-6941.2010.00916.x (2010).","journal-title":"FEMS Microbiol Ecol"},{"key":"BFsrep37082_CR51","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.4049\/jimmunol.169.9.5308","volume":"169","author":"G Bamias","year":"2002","unstructured":"Bamias, G. et al. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn\u2019s disease. J Immunol 169, 5308\u20135314 (2002).","journal-title":"J Immunol"},{"key":"BFsrep37082_CR52","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1046\/j.1365-2036.2001.01111.x","volume":"15","author":"S Colpaert","year":"2001","unstructured":"Colpaert, S. et al. Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model. Aliment Pharmacol Ther 15, 1827\u20131836 (2001).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep37082_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.intimp.2007.10.018","volume":"8","author":"M Fararjeh","year":"2008","unstructured":"Fararjeh, M., Mohammad, M. K., Bustanji, Y., Alkhatib, H. & Abdalla, S. Evaluation of immunosuppression induced by metronidazole in Balb\/c mice and human peripheral blood lymphocytes. International immunopharmacology 8, 341\u2013350, doi: 10.1016\/j.intimp.2007.10.018 (2008).","journal-title":"International immunopharmacology"},{"key":"BFsrep37082_CR54","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/ajg.2011.72","volume":"106","author":"KJ Khan","year":"2011","unstructured":"Khan, K. J. et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. The American journal of gastroenterology 106, 661\u2013673, doi: 10.1038\/ajg.2011.72 (2011).","journal-title":"The American journal of gastroenterology"},{"key":"BFsrep37082_CR55","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3892\/etm.2012.718","volume":"4","author":"SL Wang","year":"2012","unstructured":"Wang, S. L., Wang, Z. R. & Yang, C. Q. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med 4, 1051\u20131056, doi: 10.3892\/etm.2012.718 (2012).","journal-title":"Exp Ther Med"},{"key":"BFsrep37082_CR56","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0016-5085(00)70362-3","volume":"118","author":"KL Madsen","year":"2000","unstructured":"Madsen, K. L. et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118, 1094\u20131105 (2000).","journal-title":"Gastroenterology"},{"key":"BFsrep37082_CR57","doi-asserted-by":"publisher","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","volume":"299","author":"MO Griffin","year":"2010","unstructured":"Griffin, M. O., Fricovsky, E., Ceballos, G. & Villarreal, F. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299, C539\u2013C548, doi: 10.1152\/ajpcell.00047.2010 (2010).","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFsrep37082_CR58","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1529-0131(199705)40:5&lt;842::AID-ART9&gt;3.0.CO;2-1","volume":"40","author":"JR O\u2019Dell","year":"1997","unstructured":"O\u2019Dell, J. R. et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 40, 842\u2013848, doi: 10.1002\/1529-0131(199705)40:5&lt;842::AID-ART9&gt;3.0.CO;2-1 (1997).","journal-title":"Arthritis Rheum"},{"key":"BFsrep37082_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ana.10092","volume":"51","author":"N Popovic","year":"2002","unstructured":"Popovic, N. et al. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51, 215\u2013223 (2002).","journal-title":"Ann Neurol"},{"key":"BFsrep37082_CR60","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1007\/s11064-011-0522-2","volume":"36","author":"C Yi","year":"2011","unstructured":"Yi, C. et al. Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis. Neurochem Res 36, 1984\u20131990, doi: 10.1007\/s11064-011-0522-2 (2011).","journal-title":"Neurochem Res"},{"key":"BFsrep37082_CR61","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/AAC.16.5.554","volume":"16","author":"G Banck","year":"1979","unstructured":"Banck, G. & Forsgren, A. Antibiotics and suppression of lymphocyte function in vitro. Antimicrobial agents and chemotherapy 16, 554\u2013560 (1979).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep37082_CR62","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2249.1995.tb03864.x","volume":"102","author":"M Kloppenburg","year":"1995","unstructured":"Kloppenburg, M. et al. The influence of tetracyclines on T cell activation. Clinical and experimental immunology 102, 635\u2013641 (1995).","journal-title":"Clinical and experimental immunology"},{"key":"BFsrep37082_CR63","doi-asserted-by":"publisher","first-page":"11275","DOI":"10.1074\/jbc.M110.210518","volume":"286","author":"GL Szeto","year":"2011","unstructured":"Szeto, G. L., Pomerantz, J. L., Graham, D. R. & Clements, J. E. Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells. J Biol Chem 286, 11275\u201311282, doi: 10.1074\/jbc.M110.210518 (2011).","journal-title":"J Biol Chem"},{"key":"BFsrep37082_CR64","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.intimp.2011.03.011","volume":"11","author":"Y Huang","year":"2011","unstructured":"Huang, Y. et al. Doxycycline up-regulates the expression of IL-6 and GM-CSF via MAPK\/ERK and NF-kappaB pathways in mouse thymic epithelial cells. International immunopharmacology 11, 1143\u20131149, doi: 10.1016\/j.intimp.2011.03.011 (2011).","journal-title":"International immunopharmacology"},{"key":"BFsrep37082_CR65","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120, doi: 10.1093\/bioinformatics\/btu170 (2014).","journal-title":"Bioinformatics"},{"key":"BFsrep37082_CR66","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323, doi: 10.1186\/1471-2105-12-323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"BFsrep37082_CR67","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140, doi: 10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"BFsrep37082_CR68","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome biology 11, R25, doi: 10.1186\/gb-2010-11-3-r25 (2010).","journal-title":"Genome biology"},{"key":"BFsrep37082_CR69","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/bioinformatics\/bts587","volume":"28","author":"CJ Chen","year":"2012","unstructured":"Chen, C. J. et al. ncPRO-seq: a tool for annotation and profiling of ncRNAs in sRNA-seq data. Bioinformatics 28, 3147\u20133149, doi: 10.1093\/bioinformatics\/bts587 (2012).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep37082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37082","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:48:11Z","timestamp":1672886891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep37082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep37082"],"URL":"https:\/\/doi.org\/10.1038\/srep37082","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]},"assertion":[{"value":"14 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F. Hoffmann-La Roche, Ltd. (Basel, Switzerland) supported this study by an unrestricted research grant. Responsibility for opinions, conclusions, and interpretation of data lies with the authors. No author receives stipends or acts in any other consultative capacity for Roche. Roche had no influence on the design of the studies presented but approved the study protocol developed by the investigators. All analyses were performed solely by the investigators; Roche had no influence on the analyses performed or data interpretation. Decisions as to the data presented were made solely by the investigators with no input from Roche. Manuscript development, review and editing were performed without any input from, or sharing with Roche at any point. Roche provided only financial resources with no access to content.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37082"}}